(Information sent by the signatory company)

- Research topic: new strategies to involve neurophils in solid tumors -

OSAKA, Japan, Jan. 9, 2024/PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan) reported that it has entered into a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting to researchers interested in this research project through BioMed X.

For more information, please see the following BioMed X press release and application guidelines for the research project:

BioMed X Press Release December 19, 2023: BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research

Application Guidelines for Research Project: Call for Application

(Application Summary) For more information, see the link above. Research topic: New strategies to involve neutrophils in solid tumors Project duration: 3 - 5 years Application deadline: February 18, 2024

Logo - https://mma.prnewswire.com/media/1636289/ONO_PHARMA_USA_Logo.jpg

View original content: https://www.prnewswire.com/es/comunicados-de-prensa/convocatoria-para-investigadores-para-proyecto-de-investigacion-conjunto-entre-ono-pharmaceutical-y-biomed-x-302029869.html